{"id":6956,"date":"2025-05-22T12:31:04","date_gmt":"2025-05-22T09:31:04","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=6956"},"modified":"2025-05-22T12:31:04","modified_gmt":"2025-05-22T09:31:04","slug":"redo-savr-surgical-aortic-valve-replacement-after-failed-tavr-higher-risk-but-feasible-option","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/redo-savr-surgical-aortic-valve-replacement-after-failed-tavr-higher-risk-but-feasible-option\/","title":{"rendered":"\u200fRedo SAVR \u00a0(Surgical Aortic Valve Replacement)\u00a0 After Failed TAVR: Higher Risk but Feasible Option."},"content":{"rendered":"<div>\u200fRedo SAVR<\/div>\n<div>\u00a0(Surgical Aortic Valve Replacement)\u00a0 After Failed TAVR: Higher Risk but Feasible Option.<\/div>\n<div><\/div>\n<div>Source: The Annals of Thoracic Surgery \u2013 University of Alabama at Birmingham (UAB)<\/div>\n<div>Date: 2025<\/div>\n<div><\/div>\n<div>Key Summary:<\/div>\n<div><span> 1. Background:<\/span><\/div>\n<div><span> \u2022 Redo-TAVR is not always feasible when a transcatheter valve fails.<\/span><\/div>\n<div><span> \u2022 TAVR explantation followed by surgical aortic valve replacement (SAVR) is being performed more frequently, though it remains a high-risk surgical procedure\u2014often considered twice as complex as standard SAVR.<\/span><\/div>\n<div><span> 2. Study Data (UAB):<\/span><\/div>\n<div><span> \u2022 From over 2,000 TAVR patients, 33 underwent TAVR explant followed by SAVR.<\/span><\/div>\n<div><span> \u2022 Average age: 75 years; STS-PROM score: 5.49%.<\/span><\/div>\n<div><span> \u2022 Most common indication: bioprosthetic valve degeneration.<\/span><\/div>\n<div><span> 3. Surgical Approach:<\/span><\/div>\n<div><span> \u2022 All surgeries were performed via median sternotomy with cardiopulmonary bypass and myocardial arrest using cardioplegia.<\/span><\/div>\n<div><span> \u2022 No Bentall procedures required; aortic root repair was performed in 3 cases.<\/span><\/div>\n<div><span> 4. Outcomes:<\/span><\/div>\n<div><span> \u2022 Survival rates: 94% at 30 days, 81.4% at 1 year, and 61.6% at 3 years.<\/span><\/div>\n<div><span> \u2022 Perioperative mortality: 6% (2 deaths).<\/span><\/div>\n<div><span> \u2022 Average hospital length of stay: 10 days.<\/span><\/div>\n<div><span> 5. Clinical Insight:<\/span><\/div>\n<div><span> \u2022 These represent some of the best short- and mid-term outcomes published to date for this very high-risk patient population.<\/span><\/div>\n<div><span> \u2022 The results underscore the importance of surgical expertise, multidisciplinary planning, and tailored postoperative care.<\/span><\/div>\n<div><a href=\"https:\/\/www.annalsthoracicsurgery.org\/article\/S0003-4975(25)00407-2\/abstract\">https:\/\/www.annalsthoracicsurgery.org\/article\/S0003-4975(25)00407-2\/abstract<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u200fRedo SAVR \u00a0(Surgical Aortic Valve Replacement)\u00a0 After Failed TAVR: Higher Risk but Feasible Option. Source: The Annals of Thoracic Surgery \u2013 University of Alabama at Birmingham (UAB) Date: 2025 Key Summary: 1. Background: \u2022 Redo-TAVR is not always feasible when a transcatheter valve fails. \u2022 TAVR explantation followed by surgical aortic valve replacement (SAVR) is [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-6956","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/6956","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=6956"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/6956\/revisions"}],"predecessor-version":[{"id":6957,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/6956\/revisions\/6957"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=6956"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=6956"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=6956"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}